Inventor

HAUSHEER FREDERICK H

US71 patents

⚠️ This page may combine multiple inventors who share the name “HAUSHEER FREDERICK H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAUSHEER FREDERICK H

BIONUMERIK PHARMACEUTICALS INC

Formulations and compositions of poorly water soluble camptothecin derivatives

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Pharmaceutical formulations of highly lipophilic camptothecin derivatives

Formulations and compositions of poorly water soluble camptothecin derivatives

Formulations and compositions of poorly water soluble camptothecin derivatives

Lactone stable formulation of 7-ethyl 10-hydroxy camptothecin and methods for uses thereof

11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof

Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof

Sterile aqueous parenteral formulations of cis-diammine dichloro platinum

Highly lipophilic camptothecin derivatives

Chemoprotective methods and compositions

Method for treating cancer having greater efficacy and reduced adverse effects

Highly lipophilic Camptothecin derivatives

Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof

Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof

Lactone stable formulation of camptothecin and methods for uses thereof

Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP

Pharmaceutical formulations of highly lipophilic camptothecin derivatives

Formulations and compositions of poorly water soluble camptothecin derivatives

Monoazole ligand platinum analogs

Highly lipophilic camptothecin derivatives

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP

11,7 Substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof

Highly lipophilic camptothecin derivatives

Formulations and methods of reducing toxicity of antineoplastic agents

Combination of MDAM and 5-fluoropyrimidines for treating cancer

Mercaptans and disulfides

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Formulations and methods of reducing toxicity of antineoplastic agents

Reducing toxic effects of carboplatin using dithioethers

Method of treating diabetic nephropathy

Highly lipophilic camptothecin derivatives

Method for reducing development of free radical induced malignancies

Method of treating diabetic cardiomyopathy

HAUSHEER FREDERICK H

Chemoprotective methods

Compositions and methods of use of compounds to increase cancer patient survival time

Increasing cancer patient survival time by administration of dithio-containing compounds

Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity

STERLING DRUG INC

Nuclease resistant compounds

Exonuclease resistant terminally substituted oligonucleotides

BIO NUMERIK PHARMACEUTICALS IN

Method of treating patients undergoing kidney dialysis

(unassigned)

Method of treating acetaminophen overdose